Doctor payments drove scripts for cancer drugs from Pfizer, Novartis and more: study

Are physicians who receive money from drug companies more likely to prescribe the treatments tied to that cash? A new study suggests that consistent payments—not mere payments themselves—are more likely to sway prescribing.